Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2023-05-24 00:00:00 ET · period of report 2023-05-22 · accession 0001209191-23-031882 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-24 | 2023-05-22 | VIR | NELSEN ROBERT | Dir, 10% | A - Grant | $0.00 | +6,027 | 576.1K | +1% | $0 |
| D | 2023-05-24 | 2023-05-22 | VIR | NELSEN ROBERT | Dir, 10% | A - Grant | $0.00 | +12.1K | 12.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-22 | A | A | 6,027 | $0.00 | 576,148 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-05-22 | A | A | 12,054 | $0.00 | 12,054 | D | $25.74 · 2024-05-22 to 2033-05-21 | 12,054 Common Stock |